Home » Newsletters » BioWorld Science

BioWorld Science

June 21, 2018

View Archived Issues

7 Hills Pharma receives support from NIH to develop next-generation integrin activator

Luye cleared for phase I trials in China with LY-03012

Cytokinetics presents data from phase II study of reldesemtiv

Novel collaborative agreement to develop Nanotaxi-formulated DNA dengue vaccine

Missense mutations in GLIS1 gene are linked to malformation syndromes

Phase II dose of BAL-101553 defined in solid tumors trial

GSX2 gene identified as causative of basal ganglia agenesis

Moxetumomab pasudotox pivotal trial data in relapsed/refractory hairy cell leukemia reported

Loss-of-function mutation in TCF12 gene linked to autosomal dominant Kallmann syndrome

Aquinnah Pharmaceuticals obtains NINDS grant to develop ALS drugs

New phase II trial studies arimoclomol for Gaucher's disease

Atossa completes dosing in phase I study of topical endoxifen

Immune Design opens phase III study of CMB-305 for synovial sarcoma

FDA approves use of Cinryze to prevent angioedema attacks in pediatric patients with HAE

PATH and SD Biosensor partner on new diagnostic for G6PD deficiency in malaria

Kiyatec initiates 3D-PREDICT study with EV3D assay

Xalud initiates phase I trial of XT-150 for osteoarthritic pain

TG Therapeutics and Novimmune enter global agreement to develop and commercialize TG-1801

Insights into the orthosteric and allosteric action of C5aR antagonists to guide drug development

Teijin Pharma presents CDK4/cyclin D3 and/or CDK6/cyclin D3 inhibitors

Amgen discovers apelin receptor agonists

MTHFD2 inhibitors identified at Daiichi Sankyo

Shanghai Meton Pharmaceutical patents NADP+ inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...